Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.5K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.5K
Gram-negative Bacterial Protein Secretion Systems01:17

Gram-negative Bacterial Protein Secretion Systems

914
Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
914
Antibiotic Selection00:57

Antibiotic Selection

59.9K
Overview
59.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

38.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.5K
Positive, Negative, and Zero Work00:58

Positive, Negative, and Zero Work

22.2K
Work is done on an object when energy is transferred to the object. In other words, work is done when a force acts on a body that undergoes a displacement from one position to another. By definition, the work done by a force is the integral of the force with respect to the displacement along its path. Forces can vary as a function of position, and displacements can occur along various paths between two points. The magnitude of a force multiplied by the cosine of the angle that the force makes...
22.2K
Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.

The Journal of infection·2022
Same author

Nosocomial influenza in south-western Swiss hospitals during two seasonal epidemics: an observational study.

The Journal of hospital infection·2021
Same author

Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector.

Scientific reports·2019
Same author

Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

Re: "Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis" by Horita et al.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

Novel strategies for targeting innate immune responses to influenza.

Mucosal immunology·2016

Related Experiment Video

Updated: Feb 1, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

11.4K

Antibiotic therapy for gram-negative bacteremia.

T Calandra1, A Cometta

  • 1Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Infectious Disease Clinics of North America
|December 1, 1991
PubMed
Summary

Early, appropriate antibiotic treatment is crucial for gram-negative bacillary bacteremia. Monitoring antibiotic levels in critically ill patients is recommended to ensure therapeutic efficacy and prevent relapses.

More Related Videos

Rapid Identification of Gram Negative Bacteria from Blood Culture Broth Using MALDI-TOF Mass Spectrometry
13:29

Rapid Identification of Gram Negative Bacteria from Blood Culture Broth Using MALDI-TOF Mass Spectrometry

Published on: May 28, 2014

25.0K
Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria
12:57

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria

Published on: September 16, 2013

32.8K

Related Experiment Videos

Last Updated: Feb 1, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

11.4K
Rapid Identification of Gram Negative Bacteria from Blood Culture Broth Using MALDI-TOF Mass Spectrometry
13:29

Rapid Identification of Gram Negative Bacteria from Blood Culture Broth Using MALDI-TOF Mass Spectrometry

Published on: May 28, 2014

25.0K
Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria
12:57

Isolation and Chemical Characterization of Lipid A from Gram-negative Bacteria

Published on: September 16, 2013

32.8K

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Critical Care Medicine

Background:

  • Gram-negative bacillary bacteremia requires comprehensive management beyond antibiotics, including addressing underlying conditions and supportive care.
  • Focus has shifted to antibiotic evaluation since the late 1960s, with early treatment significantly improving outcomes and preventing septic shock.
  • Subinhibitory antibiotic levels can lead to treatment failure; thus, monitoring serum concentrations in critically ill patients is advised.

Purpose of the Study:

  • To review the evolution and current strategies for treating gram-negative bacillary bacteremia, particularly in neutropenic patients.
  • To evaluate the efficacy of different antibiotic regimens, including monotherapy versus combination therapy.
  • To highlight the importance of considering patient-specific factors and the limitations of existing studies.

Main Methods:

  • Literature review of clinical studies on gram-negative bacteremia treatment, focusing on antibiotic therapy.
  • Analysis of studies conducted in both non-neutropenic and neutropenic populations, including cancer patients.
  • Comparison of outcomes from single-agent therapy versus combination antibiotic therapies.

Main Results:

  • Early empirical antibiotic therapy has been shown to reduce mortality in gram-negative bacteremia.
  • Combination antibiotic therapy (e.g., extended-spectrum penicillin plus aminoglycoside or third-generation cephalosporin) improved outcomes.
  • Triple-drug combinations offer no significant advantage over dual-drug regimens; monotherapy's equivalence to combination therapy remains unproven, especially in specific patient groups.

Conclusions:

  • While broad-spectrum single-agent therapy with third-generation cephalosporins or carbapenems is an option, its equivalence to combination therapy requires further definitive studies.
  • Careful consideration of patient prognosis, pathogen (e.g., P. aeruginosa), and granulocytopenia severity is essential when selecting treatment.
  • The limitations of small studies, including the risk of type II errors, necessitate cautious interpretation of findings.